Minovar (603538.SH) participated in the 4th to 5th batch of centralized procurement of nationally organized drugs selected by the Jiangsu Alliance for successive procurement

Zhitongcaijing · 11/26 08:17

Zhitong Finance App News, Minovar (603538.SH) announced that recently, the official website of the Jiangsu Provincial Medical Security Administration issued the “Jiangsu Alliance Continued Procurement Notice (5)”. Ningbo Menohuatiankang Pharmaceutical Co., Ltd. (“Minovar Tiankang”), a wholly-owned subsidiary of the company, won the bid for duloxetine hydrochloride enteric capsules and engagliptin tablets.

In the follow-up procurement project of the Jiangsu Alliance for the 4th to 5th batch of centralized drug procurement by the National Organization, Menovartin Tiankang's duloxetine hydrochloride enteric capsules and englizine tablets completed the bid renewal process for centralized drug procurement by the national organization, and the selected price ranked 50% from the lowest to the highest. Medical institutions will give priority to using the products selected in this centralized drug procurement.